Author: Worm, Margitta; Bauer, Andrea; Wedi, Bettina; Treudler, Regina; Pfuetzner, Wolfgang; Brockow, Knut; Buhl, Timo; Zuberbier, Torsten; Fluhr, Joachim; Wurpts, Gerda; Klimek, Ludger; Jacob, Thilo; Merk, Hans F.; Mülleneisen, Norbert; Roeseler, Stefani; Dickel, Heinrich; Raap, Ulrike; Kleine-Tebbe, Jörg
Title: Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany Cord-id: vj7go7dk Document date: 2021_1_26
ID: vj7go7dk
Snippet: Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylax
Document: Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date